TNF and inflammatory bowel disease: Identifying which patients with IBD are at risk of failure of anti-TNF drugs and which have a high probability of maintaining a response to anti-TNF drugs over a long period would help considerably in personalizing treatments and avoiding the use of immunosuppressants in individuals for whom they are not necessary.